The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

ORLANDO, May 17 – A new treatment option for inoperable primary liver cancer called TheraSphere® appears to be safe and effective for liver cancer patients, according to results presented by a ...

OTTAWA , Feb. 5 /CNW/ - MDS Nordion, a global leader in providing products and services for medical imaging and radiotherapeutics, today announced that two of the largest health insurers in the United ...

Patients with this liver cancer subtype do not need to be hospitalized to receive this treatment and, according to the agent’s manufacturer, Boston Scientific, can typically receive the therapy in ...

NICE has issued guidance recommending the use of TheraSphere Y-90 Glass Microspheres, from Boston Scientific, as a treatment for patients with HCC. The National Institute for Health and Care ...

London, UK, 26 January 2016: BTG plc (LSE: BTG), the specialist healthcare company, today announced the first treatment of patients in South Korea with TheraSphere® – a treatment for primary liver ...

Leading Istanbul hospital will host news conference to educate public about a safe, well-tolerated and innovative treatment TheraSphere, available in 16 countries around the world, is a targeted liver ...

Boston Scientific Corporation BSX recently announced receipt of the FDA’s approval for its TheraSphere Y-90 Glass Microspheres, which have been developed for the treatment of hepatocellular carcinoma ...